DYN Key Financial Ratios - Dyne Therapeutics, Inc.

Complete source-backed ratio history.

Historical Key Financial Ratios

Date	Current ratio	Debt/equity	ROA	ROE
2026-06-30	12.02	—	-52.25%	-73.97%
2026-03-31	19.92	—	-41.83%	-52.22%
2025-12-31	22.25	—	-37.59%	-45.90%
2025-09-30	13.47	—	-48.88%	-61.26%
2025-06-30	16.83	—	-56.64%	-72.25%
2025-03-31	20.35	—	-50.91%	-54.88%
2024-12-31	15.6	—	-45.92%	-50.40%
2024-09-30	17.02	—	-38.31%	-41.74%
2024-06-30	26.63	—	-31.19%	-33.23%
2024-03-31	21.83	—	-49.28%	-53.84%
2023-12-31	2.53	—	-142.92%	-258.44%
2023-09-30	5.67	—	-101.40%	-136.89%
2023-06-30	10.54	—	-75.29%	-91.50%
2023-03-31	11.54	—	-61.22%	-73.04%
2022-12-31	9.46	—	-54.88%	-66.61%
2022-09-30	11.07	—	-60.42%	-72.50%
2022-06-30	11.63	—	-53.60%	-63.49%
2022-03-31	14.82	—	-41.24%	-47.53%
2021-12-31	13.31	—	-35.07%	-40.55%
2021-09-30	18.19	—	-27.02%	-30.46%
2021-06-30	—	—	-20.87%	-21.54%
2021-03-31	—	—	-15.56%	-16.00%
2020-12-31	31.83	—	-16.82%	-17.36%
2020-09-30	81.2	—	-9.49%	-9.87%
2020-06-30	—	—	—	3914.05%
2020-03-31	—	—	—	-252.28%
2019-12-31	6.26	—	-90.40%	-105.86%

Date	Current ratio	Debt/equity	ROA	ROE
2025-12-31	22.25	—	-37.59%	-45.90%
2024-12-31	15.6	—	-45.92%	-50.40%
2023-12-31	2.53	—	-142.92%	-258.44%
2022-12-31	9.46	—	-54.88%	-66.61%
2021-12-31	13.31	—	-35.07%	-40.55%
2020-12-31	31.83	—	-16.82%	-17.36%
2019-12-31	6.26	—	-90.41%	-105.86%